Greater accuracy in gauging blood coagulation

Feb 23, 2012

Thrombin plays a key role in various pathologies of the haemostatic system. Overexpression of thrombin can result in thrombosis, whereas its underexpression might lead to haemophilia. Therefore, accurate monitoring of thrombin activity is crucial for determining the proper treatment of a given patient, as this correlates with the ability of blood to coagulate. A tool for monitoring the activity of thrombin over time is the so-called thrombin generation test (TGT).

In a collaborative project headed by Floris Rutjes (Radboud University Nijmegen, Netherlands), novel thrombin-specific fluorogenic peptides were developed for accurately determining thrombin concentrations by the TGT.

Adding such a peptide substrate to a clotting plasma sample results in its by thrombin, thereby releasing the fluorophore.

Spectrophotometric measurement of fluorophore release increases the sensitivity and thus accuracy of the TGT, yielding various essential coagulation parameters.

The use of fluorogenic peptides in combination with the TGT is expected to find broad application in the field of haemostasis and .

Explore further: Scientists "resurrect" ancient proteins to learn about primordial life on Earth

More information: Floris P. J. T. Rutjes, Fluorogenic Peptide-Based Substrates for Monitoring Thrombin Activity, ChemMedChem, dx.doi.org/10.1002/cmdc.201100560

add to favorites email to friend print save as pdf

Related Stories

FDA OKs new adhesive to treat burn victims

Mar 20, 2008

The U.S. Food and Drug Administration approved a medical adhesive -- a fibrin sealant called Artiss -- for use in attaching skin grafts to burn patients.

Blood-clotting protein linked to cancer and septicemia

Feb 04, 2011

In our not-so-distant evolutionary past, stress often meant imminent danger, and the risk of blood loss, so part of our body's stress response is to stock-pile blood-clotting factors. Scientists in the Molecular Medicine ...

Blood clotting and bowel cancer risk

Jun 06, 2011

Back in the mid 19th century, a French doctor, Armand Trousseau, discovered a connection between cancer and thrombosis – the formation of often dangerous blood clots that can lead to venous occlusion. Today it is known ...

Recommended for you

Driving cancer cells to suicide

8 hours ago

Ludwig Maximilian University of Munich researchers report that a new class of chemical compounds makes cancer cells more sensitive to chemotherapeutic drugs. They have also pinpointed the relevant target ...

User comments : 0